MASIMO CORPORATION
NASDAQ: MASI (Masimo Corporation)
Last update: yesterday, 7:47PM169.52
-0.48 (-0.28%)
| Previous Close | 170.00 |
| Open | 166.97 |
| Volume | 796,159 |
| Avg. Volume (3M) | 686,863 |
| Market Cap | 9,100,291,072 |
| Price / Earnings (TTM) | 117.72 |
| Price / Sales | 4.64 |
| Price / Book | 6.37 |
| 52 Weeks Range | |
| Earnings Date | 24 Feb 2025 - 3 Mar 2025 |
| Profit Margin | 3.85% |
| Operating Margin (TTM) | 5.97% |
| Diluted EPS (TTM) | 1.44 |
| Quarterly Revenue Growth (YOY) | 5.40% |
| Quarterly Earnings Growth (YOY) | -7.50% |
| Total Debt/Equity (MRQ) | 58.84% |
| Current Ratio (MRQ) | 2.01 |
| Operating Cash Flow (TTM) | 223.00 M |
| Levered Free Cash Flow (TTM) | 148.48 M |
| Return on Assets (TTM) | 2.66% |
| Return on Equity (TTM) | 5.74% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Masimo Corporation | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | -4.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | 2.0 |
| Average | 1.75 |
|
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 8.19% |
| % Held by Institutions | 94.99% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Politan Capital Management Lp | 30 Sep 2024 | 4,714,746 |
| Ace Management Global Ltd. | 30 Sep 2024 | 965,504 |
| Liontrust Investment Partners Llp | 30 Sep 2024 | 808,693 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 210.00 (Piper Sandler, 23.88%) | Buy |
| Median | 190.00 (12.08%) | |
| Low | 170.00 (Raymond James, 0.28%) | Buy |
| 170.00 (BTIG, 0.28%) | Buy | |
| Average | 186.60 (10.08%) | |
| Total | 5 Buy | |
| Avg. Price @ Call | 165.99 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Piper Sandler | 18 Dec 2024 | 210.00 (23.88%) | Buy | 170.63 |
| 06 Nov 2024 | 180.00 (6.18%) | Buy | 167.63 | |
| Wells Fargo | 11 Dec 2024 | 193.00 (13.85%) | Buy | 174.38 |
| 06 Nov 2024 | 171.00 (0.87%) | Buy | 167.63 | |
| Stifel | 22 Nov 2024 | 190.00 (12.08%) | Buy | 172.96 |
| Raymond James | 06 Nov 2024 | 170.00 (0.28%) | Buy | 167.63 |
| BTIG | 14 Oct 2024 | 170.00 (0.28%) | Buy | 144.35 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 26 Nov 2024 | Announcement | Masimo to Present in the Piper Sandler 36th Annual Healthcare Conference |
| 14 Nov 2024 | Announcement | Masimo to Present in the Jefferies London Healthcare Conference |
| 13 Nov 2024 | Announcement | Masimo to Present in Stifel 2024 Healthcare Conference |
| 05 Nov 2024 | Announcement | Masimo Reports Third Quarter 2024 Financial Results |
| 29 Oct 2024 | Announcement | Vanderbilt University Medical Center Integrates Masimo Radius VSM™ in Proactive Care Protocol to Combat Emergency Room Congestion |
| 22 Oct 2024 | Announcement | Masimo to Report Third Quarter 2024 Financial Results after Market Close on Tuesday, November 5 |
| 18 Oct 2024 | Announcement | Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors |
| 25 Sep 2024 | Announcement | Masimo Provides Leadership and Business Updates |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |